Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial.
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751
Informations de publication
Date de publication:
15 06 2022
15 06 2022
Historique:
received:
25
06
2021
revised:
18
10
2021
accepted:
23
11
2021
pubmed:
2
12
2021
medline:
18
6
2022
entrez:
1
12
2021
Statut:
ppublish
Résumé
The extent to which use of electronic nicotine delivery systems (ENDS) for smoking reduction leads to cigarette abstinence in smokers with no plans to quit smoking is unclear. This exploratory analysis examined the effects of ENDS delivering different amounts of nicotine on cigarette abstinence up to 24-week follow-up, in comparison to placebo or a behavioral substitute. This four-arm parallel-group, randomized, placebo-controlled trial took place at two academic medical centers in the United States (Penn State Hershey and Virginia Commonwealth University). Participants were current adult smokers (N = 520) interested in reducing but not planning to quit. They received brief advice and were randomized to one of four 24-week conditions, receiving either an eGo-style ENDS paired with 0, 8, or 36 mg/ml nicotine liquid (double-blind) or a cigarette-shaped tube, as a cigarette substitute (CS). Self-reported daily cigarette consumption and exhaled carbon monoxide (CO) were measured at all study visits. Outcomes included intent-to-treat, self-reported 7-day cigarette abstinence, biochemically confirmed by exhaled CO at 24 weeks after randomization. At 24 weeks, significantly more participants in the 36 mg/ml condition (14/130, 10.8%) than in the 0 mg/ml condition (1/130, 0.8%) and the CS condition (4/130, 3.1%) were abstinent (relative risk = 14 [95% CI = 1.9-104.9] and 3.5 [95% CI = 1.2-10.4], respectively). The abstinence rate in the 8 mg/ml condition was 4.6% (6/130). When smokers seeking to reduce smoking tried ENDS, few quit smoking in the short term. However, if smokers continued to use an ENDS with cigarette-like nicotine delivery, a greater proportion completely switched to ENDS, as compared with placebo or a cigarette substitute. The extent to which use of electronic nicotine delivery systems (ENDS) for smoking reduction leads to cigarette abstinence in smokers with no plans to quit smoking was unclear. This randomized trial found that ENDS with nicotine delivery approaching that of a cigarette are more effective in helping ambivalent smokers to quit cigarette smoking.
Identifiants
pubmed: 34850164
pii: 6444300
doi: 10.1093/ntr/ntab247
pmc: PMC9391685
doi:
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, U.S. Gov't, P.H.S.
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
955-961Subventions
Organisme : NIDA NIH HHS
ID : P50 DA036105
Pays : United States
Organisme : NIDA NIH HHS
ID : U54 DA036105
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002014
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002649
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Addict Behav. 2020 Apr;103:106222
pubmed: 31838445
Lancet. 2013 Nov 16;382(9905):1629-37
pubmed: 24029165
Lancet Respir Med. 2021 Aug;9(8):840-850
pubmed: 33857436
Nicotine Tob Res. 2022 Feb 14;24(3):324-332
pubmed: 34313780
Cochrane Database Syst Rev. 2019 Apr 18;4:CD013308
pubmed: 30997928
Exp Clin Psychopharmacol. 2017 Oct;25(5):380-392
pubmed: 29048187
Tob Regul Sci. 2016 Apr;2(2):133-145
pubmed: 27042688
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Nicotine Tob Res. 2015 Feb;17(2):186-92
pubmed: 25332459
J Am Board Fam Med. 2019 Jul-Aug;32(4):567-574
pubmed: 31300577
Nicotine Tob Res. 2020 Aug 24;22(9):1524-1532
pubmed: 31828315
Lancet Respir Med. 2020 Jan;8(1):54-64
pubmed: 31515173
Tob Control. 2019 Jan;28(1):42-49
pubmed: 29574448
PLoS One. 2019 Jul 25;14(7):e0220300
pubmed: 31344110
BMJ. 2009 Apr 02;338:b1024
pubmed: 19342408
BMC Public Health. 2016 Mar 03;16:217
pubmed: 26941050
Addiction. 2020 Apr;115(4):757-767
pubmed: 31691397
Harm Reduct J. 2011 Sep 13;8:25
pubmed: 21914165
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
Nicotine Tob Res. 2015 Feb;17(2):158-62
pubmed: 25180079